Research: Informed Container Choices Reduce Risk and Cost for Temperature-Sensitive Pharmaceutical Shipments

Jun 19, 2018

Peli BioThermal white paper addresses active and passive container options and provides selection guidance Peli BioThermal, the global name in temperature controlled packaging, recently released a white paper addressing market solutions for protecting  temperature-sensitive pharmaceuticals while in transit. The white paper, titled “Active Shipping Containers vs Passive Shipping Containers,” provides guidance on making the optimum choice to eliminate confusion, reduce risk and save money evaluating the two main classes of containers used to ship temperature-sensitive pharmaceutical products. “When it comes to maintaining the clinical efficacy of pharmaceuticals, one of the most important criteria is often temperature,” said Kevin Lawler, VP ...

Read More

Early Interventions to Reduce the Impact of Immunogenicity on the Development of Biopharmaceuticals

Jan 4, 2018

The development of biological therapeutics has led to remarkable clinical benefits in many indications. But, despite this success, the induction of anti-drug antibodies (ADAs) due to the potential immunogenicity of these therapeutics, remains a significant challenge to the successful development of biotherapeutics. In their paper, Dr Karen Hill and Dr Gary Bembridge of Abzena discuss the impact of immunogenicity and approaches that can be taken in pre-clinical development to reduce the effect on product success and patient experience. ...

Read More